Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1997 2
1998 1
2000 1
2003 3
2004 3
2005 4
2006 4
2007 9
2008 4
2009 4
2010 12
2011 10
2012 6
2013 12
2014 24
2015 11
2016 24
2017 22
2018 11
2019 25
2020 20
2021 41
2022 36
2023 28
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

270 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for R. kartal
Search for R. Katal instead (3 results)
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB; LEADER Steering Committee; LEADER Trial Investigators. Marso SP, et al. N Engl J Med. 2016 Jul 28;375(4):311-22. doi: 10.1056/NEJMoa1603827. Epub 2016 Jun 13. N Engl J Med. 2016. PMID: 27295427 Free PMC article. Clinical Trial.
Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes.
Gerstein HC, Sattar N, Rosenstock J, Ramasundarahettige C, Pratley R, Lopes RD, Lam CSP, Khurmi NS, Heenan L, Del Prato S, Dyal L, Branch K; AMPLITUDE-O Trial Investigators. Gerstein HC, et al. N Engl J Med. 2021 Sep 2;385(10):896-907. doi: 10.1056/NEJMoa2108269. Epub 2021 Jun 28. N Engl J Med. 2021. PMID: 34215025 Free article. Clinical Trial.
Liraglutide and Renal Outcomes in Type 2 Diabetes.
Mann JFE, Ørsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S, Tornøe K, Zinman B, Buse JB; LEADER Steering Committee and Investigators. Mann JFE, et al. N Engl J Med. 2017 Aug 31;377(9):839-848. doi: 10.1056/NEJMoa1616011. N Engl J Med. 2017. PMID: 28854085 Free article. Clinical Trial.
Consistency across multi-omics layers in a drug-perturbed gut microbial community.
Wuyts S, Alves R, Zimmermann-Kogadeeva M, Nishijima S, Blasche S, Driessen M, Geyer PE, Hercog R, Kartal E, Maier L, Müller JB, Garcia Santamarina S, Schmidt TSB, Sevin DC, Telzerow A, Treit PV, Wenzel T, Typas A, Patil KR, Mann M, Kuhn M, Bork P. Wuyts S, et al. Mol Syst Biol. 2023 Sep 12;19(9):e11525. doi: 10.15252/msb.202311525. Epub 2023 Jul 24. Mol Syst Biol. 2023. PMID: 37485738 Free PMC article.
Irisin Protects Against Hind Limb Ischemia Reperfusion Injury.
Küçük A, Polat Y, Kılıçarslan A, Süngü N, Kartal H, Dursun AD, Arslan M. Küçük A, et al. Drug Des Devel Ther. 2021 Feb 4;15:361-368. doi: 10.2147/DDDT.S279318. eCollection 2021. Drug Des Devel Ther. 2021. PMID: 33574655 Free PMC article.
AIM: The aim of this study was to evaluate the effects of irisin in a murine model of hind limb ischemia reperfusion (I/R). METHODS: The mice were divided into four groups (n = 6 in each group): control, irisin, ischemia reperfusion (I/R), and irisin-ischemia reperf …
AIM: The aim of this study was to evaluate the effects of irisin in a murine model of hind limb ischemia reperfusion (I/R). METHODS: …
Tumour lysis syndrome in solid tumours.
Gemici C. Gemici C. Clin Oncol (R Coll Radiol). 2006 Dec;18(10):773-80. doi: 10.1016/j.clon.2006.09.005. Clin Oncol (R Coll Radiol). 2006. PMID: 17168213 Review.
Corneal opacities after small-incision lenticule extraction.
Kartal S, Nuijts RMMA, Hjortdal J, Daya S, Kweon Kim E, Sekundo W, Ganesh S, Brar S, Moshirfar M, Hansen AM, Payne CJ. Kartal S, et al. J Cataract Refract Surg. 2022 Sep 1;48(9):1097. doi: 10.1097/j.jcrs.0000000000001037. J Cataract Refract Surg. 2022. PMID: 36026475
Slitlamp biomicroscopy of the right eye and the left eye reveals hyperreflective small opacities in the anterior one-third of the corneal stroma ( Figures 1 and 2JOURNAL/jcrs/04.03/02158034-202209000-00021/figure1/v/2022-08-29T115553Z/r/image-tiffJOURNAL/jcrs/04.03/0215803 …
Slitlamp biomicroscopy of the right eye and the left eye reveals hyperreflective small opacities in the anterior one-third of the corneal st …
Drugs with a negative impact on cognitive function (Part 1): chronic kidney disease as a risk factor.
Liabeuf S, Pešić V, Spasovski G, Maciulaitis R, Bobot M, Farinha A, Wagner CA, Unwin RJ, Capasso G, Bumblyte IA, Hafez G; CONNECT Action (Cognitive Decline in Nephro-Neurology European Cooperative Target). Liabeuf S, et al. Clin Kidney J. 2023 Sep 18;16(12):2365-2377. doi: 10.1093/ckj/sfad241. eCollection 2023 Dec. Clin Kidney J. 2023. PMID: 38045996 Free PMC article. Review.
Effects of Carvedilol on liver ischemia-reperfusion injury in rats.
Kafadar MT, Gök MA. Kafadar MT, et al. Ulus Travma Acil Cerrahi Derg. 2022 Jul;28(7):885-893. doi: 10.14744/tjtes.2021.57824. Ulus Travma Acil Cerrahi Derg. 2022. PMID: 35775675 Free PMC article.
In I/R + Carvedilol group, serum MPO levels were similar to the control group. ...An increase in TNF-alpha expression was observed in hepatocyte cells of I/R group. Positive expression of caspase-3 in hepatocyte cells and a small number of endothelial and Kupffer ce …
In I/R + Carvedilol group, serum MPO levels were similar to the control group. ...An increase in TNF-alpha expression was observed in …
270 results